BMFMS: Maternal Medicine |
Chairs: Professor Fionnuala Mcauliffe, Dublin |
Dr Margaret Ramsay, Nottingham |
10.50–11.20 | Type II diabetes in pregnancy |
| Mr Andrew Dawson, Consultant Obstetrician, Nevill Hall Hospital, Gwent Healthcare NHS Trust |
11.20–11.50 | Pre-eclampsia |
| Dr Michael Belfort, Director of Perinatal Reseach & Fetal Therapy, HCA, Nashville TN, Salt Lake City, USA |
11.50–12.00 | Vascular endothelial growth factor165b and pre-eclampsia |
| VL Bills et al |
| Abstract 8.1 |
12.00–12.10 | Haemodynamic and placental markers to predict pre-eclampsia |
| A Khalil et al |
| Abstract 8.2 |
12.10–12.20 | Minimally invasive haemodynamic monitoring accurately demonstrates the profound cardiovascular effects of a 5-unit syntocinon bolus at caesarean section |
| A Carlin et al |
| Abstract 8.3 |
12.20–12.30 | Hyperemesis in pregnancy study: a randomised controlled trial of midwife-led “outpatient” care |
| C McParlin et al |
| Abstract 8.4 |